HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis
- 31 March 1995
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 108 (3) , 870-878
- https://doi.org/10.1016/0016-5085(95)90463-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epitheliumGastroenterology, 1994
- Different amino acids at position 57 of the HLA-DQβ chain associated with susceptibility and resistance to IgA deficiencyNature, 1990
- HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitusNature, 1987
- Enhanced autoreactivity of T-lymphocytes in primary sclerosing cholangitisHepatology, 1987
- GENETIC MARKERS IN NARCOLEPSYThe Lancet, 1984
- HLA antigens in Japanese patients with narcolepsyTissue Antigens, 1984
- HLA Antigens and Immunoregulatory T Cells in Ulcerative Colitis Associated with Hepatobiliary DiseaseScandinavian Journal of Gastroenterology, 1982
- Long-standing asymptomatic primary sclerosing cholangitis report of three casesDigestive Diseases and Sciences, 1981
- High Association of an HL-A Antigen, W27, with Ankylosing SpondylitisNew England Journal of Medicine, 1973
- ANKYLOSING SPONDYLITIS AND HL-A 27The Lancet, 1973